Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Daiken Medical CoTSE:7775 +0.24%62 PB Ratio is 1.57 as of Jul. 30, 2026, which is 38% below its 10-year median of 2.53. GuruFocus rates TSE:7775 with a GF Score™ of 62/100 and a GF Value™ of 円541.84 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 787 Medical Devices & Instruments companies, Daiken Medical Co ranks better than 61.37% on this metric.
Daiken Medical Co Ltd stock PB Ratio (=1.58) is close to 10-year low of 1.54.
The historical rank and industry rank for Daiken Medical Co's PB Ratio or its related term are showing as below:
TSE:7775'
s PB Ratio Range Over the Past 10 Years
Min: 1.54 Med: 2.53 Max: 3.99
Current: 1.57
During the past 13 years, Daiken Medical Co's highest PB Ratio was 3.99. The lowest was 1.54. And the median was 2.53.
TSE:7775's PB Ratio is ranked better than 61.37% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs TSE:7775: 1.57
During the past 12 months, Daiken Medical Co's average Book Value Per Share Growth Rate was 3.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 4.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 1.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Daiken Medical Co was 24.30% per year. The lowest was -4.50% per year. And the median was 5.45% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Daiken Medical Co PB Ratio Related Terms
Daiken Medical Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Daiken Medical Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Daiken Medical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiken Medical Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Daiken Medical Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Daiken Medical Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Daiken Medical Co (TSE:7775) has a PB Ratio of 1.57 as of Jul. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Daiken Medical Co and its competitors. This is 38% below median its historical median of 2.53. Over the past decade, Daiken Medical Co's PB Ratio has ranged from 1.54 to 3.99. According to the industry distribution chart, Daiken Medical Co ranks #304 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 38.6%.
Is Daiken Medical Co's PB Ratio too high?
Daiken Medical Co's current PB Ratio of 1.57 is 38% below median its 10-year median of 2.53. Over the past 10 years, this metric has ranged from a low of 1.54 to a high of 3.99. The Medical Devices & Instruments industry median PB Ratio is 2.04. Daiken Medical Co's value of 1.57 is 23% below this industry median. Based on the distribution chart, Daiken Medical Co ranks #304 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Daiken Medical Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiken Medical Co's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Daiken Medical Co ranks #304 out of 787 companies for PB Ratio. This puts Daiken Medical Co in the upper half of its industry. The industry median PB Ratio is 2.04. Daiken Medical Co's value of 1.57 is 23% below this benchmark. Historically, Daiken Medical Co's own PB Ratio has ranged from 1.54 to 3.99 over the past decade. While the company's 10-year median is 2.53 vs. the industry median of 2.04, Daiken Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiken Medical Co's current PB Ratio of 1.57 is 23% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Daiken Medical Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiken Medical Co's current PB Ratio is 1.57, which is 38% below median its own 10-year median of 2.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Daiken Medical Co (TSE:7775) is currently considered Modestly Undervalued. The stock's GF Value™ is 円541.84, compared to a current price of 円426.00 — trading 21.4% below its estimated fair value. The current PB Ratio is 1.57, which is 38% below median its 10-year median of 2.53 and 23% below the Medical Devices & Instruments industry median of 2.04. Daiken Medical Co's overall GF Score™ is 62/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Daiken Medical Co (TSE:7775), the current PB Ratio is 1.57 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daiken Medical Co (TSE:7775) Overvalued in 2026?
Based on GuruFocus' analysis, Daiken Medical Co stock appears to be undervalued.
The current stock price of 円426.00 is trading 21.4% below its estimated GF Value™ of 円541.84.
GuruFocus considers Daiken Medical Co to be Modestly Undervalued.
Key valuation signals for TSE:7775:
PB Ratio: 1.57 (38% below median its 10-year median of 2.53)
GF Value™: 円541.84 vs. price of 円426.00 (21.4% below fair value)
Industry Position: 23% below the Medical Devices & Instruments median (#304 of 787)
No single metric tells the full story. See the TSE:7775 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daiken Medical Co Ltd manufactures and sells medical equipment. The product line includes - Coopdech syrinjector, Coopdech Syrinjector PCA device, Coopdech Balloonjector, Coopdech Endobronchial blocker tube, Coopdech double-lumen endobronchial tube, Fit fix suction container system, Wet disinfectant mat, and others.
62GF Score
Get the complete analysis for TSE:7775
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7775 has been successfully added to your 
